CVR Translational Hub - Drug Screening
- Developing and screening novel antivirals and therapeutic candidates
- Identifying and validating drug targets using systems virology, functional genomics, and AI
- Supporting the early evaluation of immunotherapeutics and therapeutic antibodies
- Engaging with industry to advance therapeutic development and translation
- Supporting trial readiness and therapeutic pipelines aligned with NHS and UKHSA clinical research infrastructure
Our drug screening capabilities accelerate the development of life-saving therapeutics through cutting-edge research and strategic partnerships.
We develop and screen novel antivirals and therapeutic candidates using advanced laboratory techniques and computational methods. Our team identifies and validates promising drug targets through systems virology, functional genomics, and artificial intelligence approaches.
Our services support the early evaluation of immunotherapeutics and therapeutic antibodies, helping to streamline the path from discovery to clinical application. We actively engage with industry partners to advance therapeutic development and facilitate translation from research to real-world treatments.
Through close collaboration with NHS and UKHSA clinical research infrastructure, we support trial readiness initiatives and help build robust therapeutic pipelines that address critical public health needs.
